Darren Smith
Patrimonio netto: 131 223 $ in data 31/08/2026
Patrimonio netto: 131 223 $ in data 31/08/2026
Darren Smith is currently Director at Telix QSAM, Inc., Co-Managing Director at Rhine Pharma GmbH, Member at the Australian Institute of Co. Directors, and Group Chief Financial Officer at Telix Pharmaceuticals Ltd. since 2022.
Formerly, Mr. Smith was Global Chief Financial Officer & Secretary at Sirtex Medical Pty Ltd. from 2009 to 2019.
Education includes an undergraduate degree from the University of Western Sydney and an MBA from the Australian Graduate School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/03/2026 | 11.921 ( 0% ) | 131 223 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direttore Finanziario/CFO | 31/07/2022 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| SIRTEX MEDICAL LIMITED | Direttore Finanziario/CFO | 01/03/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of Western Sydney
University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale